All In MedTech

Company

Haemonetics

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

Haemonetics is on our public-company list (ticker HAE). Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements.

Public

Listed

HAE

NYSE · HAEMONETICS CORP

Public float

$2.23B

Value of shares held by non-insiders on Sep 27, 2025

Revenue

$1.33B

Fiscal year ending Mar 28, 2026

Net income

$97.3M

Fiscal year ending Mar 28, 2026

R&D spending

$59.8M

Fiscal year ending Mar 28, 2026

Cash

$261M

As of Sep 26, 2026

Long-term debt

$1.14B

As of Sep 26, 2026

Shares outstanding

45.5M

As of Oct 30, 2026

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2025–––$700M
2021–––$500M

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

The investor database is part of the paid tier

For Haemonetics we have 2 shareholders with 5% or more.

It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

Latest FDA decisions

Search the Clearance Tracker

5 more FDA decisions with a free account

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar

2 more trials with a free account

Reports received

2

Received Nov 1, 2025 to Nov 19, 2026

Malfunction reports

0

0.0% of reports

Injury reports

0

0.0% of reports

Death reports

2

100% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 230640
Jan 240020
Feb 240010
Mar 240030
Apr 240010
May 240010
Jun 241010
Jul 241010
Aug 242030
Sep 240010
Oct 241040
Nov 240030
Dec 240000
Jan 250020
Feb 250000
Mar 252010
Apr 250000
May 250100
Jun 250100
Jul 250000
Aug 250000
Sep 250000
Oct 250000
Nov 250000
Dec 250000
Jan 260000
Feb 260000
Mar 260000
Apr 260000
May 260000
Jun 260010
Jul 260000
Aug 260010
Sep 260000
Oct 260000
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

45 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.